GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Share-based Compensation of $35.0 million for Q1 2026, up 59.09% on a YoY basis from $22.0 million in Q1 2025, and down 2.78% quarter-over-quarter from $36.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Share-based Compensation for 5 years, with the latest figure at $35.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 59.09% year-over-year to $35.0 million; the trailing twelve-month figure through Mar 2026 stood at $143.0 million (up 26.55% YoY), and the FY2025 full-year result was $130.0 million, up 4.0% from the prior year.
- Share-based Compensation for Q1 2026 stood at $35.0 million, down from $36.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $38.0 million in Q3 2025, with the low at $9.0 million in Q4 2022.
- Historically, Share-based Compensation has averaged $27.7 million across 5 years, with a median of $29.0 million in 2023.
- Annual changes were most pronounced in 2023 — Share-based Compensation surged 266.67% — and 2025, when it sank 35.29%.
- GE HealthCare Technologies' Share-based Compensation stood at $9.0 million in 2022, then surged by 266.67% to $33.0 million in 2023, then changed by 0.0% to $33.0 million in 2024, then increased by 9.09% to $36.0 million in 2025, then dropped by 2.78% to $35.0 million in 2026.
- The last three Share-based Compensation figures came in at $35.0 million (Q1 2026), $36.0 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 24.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 36.00 Mn |
| Dec 31, 2025 | 36.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 33.00 Mn |
| Dec 31, 2024 | 33.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 33.00 Mn |
| Dec 31, 2023 | 33.00 Mn |